Effects of increased secretory SERPINE1 expression by dexmedetomidine on the malignant biological behavior of thyroid carcinoma cells

TONG Xueyan; JIANG Wenfeng; ZENG Liangping; LIN Yan

doi:10.6039/j.issn.1001-0408.2025.10.05

您当前的位置：

首页 >

文章列表页 >

Effects of increased secretory SERPINE1 expression by dexmedetomidine on the malignant biological behavior of thyroid carcinoma cells

更新时间：2025-09-23

- Effects of increased secretory SERPINE1 expression by dexmedetomidine on the malignant biological behavior of thyroid carcinoma cells
- ZHONGGUO YAOFANG Vol. 36, Issue 10, Pages: 1179-1185(2025)
- 作者机构：
  
  1.上饶市中心医院药剂科，江西上饶　334000
  2.上饶市中心医院手足显微外科，江西上饶　334000
  3.上饶市中心医院骨科，江西上饶　334000
  4.上饶市人民医院药剂科，江西上饶　334000
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2025.10.05
  CLC： R965;R736.1
- Received：24 September 2024，
  
  Revised：2025-02-28，
  
  Accepted：05 March 2025，
  
  Published：30 May 2025
- 稿件说明：
移动端阅览
童雪燕,蒋文锋,曾亮平,等.右美托咪定增加分泌型SERPINE1表达对甲状腺癌细胞恶性生物学行为的影响 [J].中国药房,2025,36(10):1179-1185.

TONG Xueyan,JIANG Wenfeng,ZENG Liangping,et al.Effects of increased secretory SERPINE1 expression by dexmedetomidine on the malignant biological behavior of thyroid carcinoma cells[J].ZHONGGUO YAOFANG,2025,36(10):1179-1185.
童雪燕,蒋文锋,曾亮平,等.右美托咪定增加分泌型SERPINE1表达对甲状腺癌细胞恶性生物学行为的影响 [J].中国药房,2025,36(10):1179-1185. DOI： 10.6039/j.issn.1001-0408.2025.10.05.

TONG Xueyan,JIANG Wenfeng,ZENG Liangping,et al.Effects of increased secretory SERPINE1 expression by dexmedetomidine on the malignant biological behavior of thyroid carcinoma cells[J].ZHONGGUO YAOFANG,2025,36(10):1179-1185. DOI： 10.6039/j.issn.1001-0408.2025.10.05.

摘要

目的

探讨右美托咪定（DEX）增加分泌型丝氨酸蛋白酶抑制剂家族E成员1（SERPINE1）蛋白表达对甲状腺癌（THCA）细胞恶性生物学行为的影响。

方法

使用1、10、100 nmol/L的DEX处理THCA细胞（KTC-1、TPC-1），检测其活力、克隆形成率、迁移率和侵袭数。通过全基因组测序和基因本体等富集分析探讨DEX在THCA中的潜在生物学功能；通过蛋白质-蛋白质相互作用网络挖掘DEX的核心靶点，并评估DEX核心靶点的表达特征及其与患者预后的关系。检测DEX对2种THCA细胞中核心靶点mRNA、蛋白表达及蛋白分泌的影响，通过敲减核心靶点来初步验证该靶点对DEX相关作用的影响。

结果

与对照（0 nmol/L DEX）组比较，1、10、100 nmol/L DEX组2种THCA细胞的活力（1 nmol/L DEX组KTC-1细胞24 h时除外）均显著升高，克隆形成率、迁移率（1 nmol/L DEX组2种THCA细胞除外）和侵袭数亦显著升高且呈浓度依赖性（

＜0.05）。DEX处理或不处理的2种THCA细胞中，共有287个差异表达基因（75个上调、212个下调），富集于磷脂酰肌醇3激酶/蛋白激酶B、Wnt和衰老相关分泌表型等信号通路；SERPINE1是DEX促THCA的核心靶点，其mRNA及蛋白在THCA组织/细胞中的表达均显著升高，且与患者的不良预后有关（

＜0.05）；与对照组比较，1、10、100 nmol/L DEX组2种THCA细胞中SERPINE1 mRNA及蛋白的表达均显著上调，且在条件培养基中该蛋白的分泌亦显著增多，均呈浓度依赖性（

＜0.05）。敲减

SERPINE1

后，DEX对2种THCA细胞增殖、克隆形成、迁移、侵袭能力的促进作用受到了显著抑制（

＜0.05）。

结论

DEX能够促进THCA细胞的增殖、迁移和侵袭，上述作用可能与增加分泌型SERPINE1蛋白的表达有关。

Abstract

OBJECTIVE

To explore the effects of dexmedetomidine （DEX） increasing serpin peptidase inhibitor clade E member 1 （SERPINE1） protein on the malignant biological behavior of thyroid carcinoma （THCA） cells.

METHODS

THCA cells （KTC-1， TPC-1） were treated with 1， 10 and 100 nmol/L DEX， and their viabilities， clone formation rates， migration rates and invasion number were examined. Potential biological functions of DEX in THCA cells were analyzed through whole genome sequencing and gene ontology enrichment analysis. The core targets of DEX were mined through a protein-protein interaction network. The expression characteristics of DEX core targets and their relationship with patient prognosis were evaluated. The effects of DEX on mRNA and protein expressions of core targets and protein secretion in 2 types of THCA cells were detected， and the effects of this target on DEX-related effects were validated preliminarily by knocking down the core target.

RESULTS

Compared with the control group （0 nmol/L DEX）， DEX at 1， 10 and 100 nmol/L significantly increased the viabilities of 2 types of THCA cells （except for the KTC-1 cells in the 1 nmol/L DEX group at 24 h）， concentration-dependently elevated the rates of clone formation， migration rates （except for 2 types of THCA cells in 1 nmol/L DEX group）， and the number of invasion （

＜0.05）. A total of 287 differently expressed genes （75 up-regulated and 212 down-regulated） were enriched in signaling pathways such as phosphatidylinositol 3-kinase/protein kinase B， Wnt， and senescence-associated secretory phenotypes in the 2 kinds of DEX-treated or non-treated THCA cells. SERPINE1 was a core target of DEX for THCA， and its mRNA and protein expression in THCA tissues/cells were significantly elevated and associated with poor prognosis of the patients （

＜0.05）. Compared with the control group， mRNA and protein expression of SERPINE1 was significantly up-regulated in 2 types of cells in the 1， 10 and 100 nmol/L DEX groups， while the secretion of this protein in conditioned medium was also significantly increased， all of which showed concentration-dependence （

＜0.05）. After knocking down

SERPINE1

， the promoting effects of DEX on the proliferation， colony formation， migration and invasion abilities of two types of THCA cells were significantly inhibited （

＜0.05）.

CONCLUSIONS

DEX can promote the proliferation， migration and invasion of THCA cell， and the above effects may be associated with the expression of increased secretory SERPINE1 protein.

关键词

Keywords

references

SUNG H ， FERLAY J ， SIEGEL R L ， et al . Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin ， 2021 ， 71 （ 3 ）： 209 - 249 .

GALLARDO E ， MEDINA J ， SÁNCHEZ J C ， et al . SEOM clinical guideline thyroid cancer：2019 [J ] . Clin Transl Oncol ， 2020 ， 22 （ 2 ）： 223 - 235 .

WANG H X ， ZHANG C ， LI Q R ， et al . Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches [J ] . BMC Cancer ， 2024 ， 24 （ 1 ）： 427 .

DE CARVALHO A Y ， KOHLER H F ， GOMES C C ， et al . Predictive factors for recurrence of papillary thyroid carcinoma：analysis of 4，085 patients [J ] . Acta Otorhinolaryngol Ital ， 2021 ， 41 （ 3 ）： 236 - 242 .

LEAL P D C ， ALBUQUERQUE M A C ， DIEGO L A D S ， et al . Anesthesia and cancer [J ] . Rev Assoc Med Bras ，（ 1992 ）， 2024 ， 70 （ Suppl. 1 ）： e2024 S 102 .

CHANG C Y ， WU M Y ， CHIEN Y J ， et al . Anesthesia and long-term oncological outcomes：a systematic review and meta-analysis [J ] . Anesth Analg ， 2021 ， 132 （ 3 ）： 623 - 634 .

YUKI K . The immunomodulatory mechanism of dexmedetomidine [J ] . Int Immunopharmacol ， 2021 ， 97 ： 107709 .

CAI Q ， LIU G Q ， HUANG L S ， et al . The role of dexmedetomidine in tumor-progressive factors in the perioperative period and cancer recurrence：a narrative review [J ] . Drug Des Devel Ther ， 2022 ， 16 ： 2161 - 2175 .

TIAN H ， HOU L ， XIONG Y M ， et al . Dexmedetomidine upregulates microRNA-185 to suppress ovarian cancer growth via inhibiting the SOX9/Wnt/β-catenin signaling pathway [J ] . Cell Cycle ， 2021 ， 20 （ 8 ）： 765 - 780 .

LIU T T ， LI R ， HUO C ， et al . Identification of CDK2-related immune forecast model and ceRNA in lung adenocarcinoma，a pan-cancer analysis [J ] . Front Cell Dev Biol ， 2021 ， 9 ： 682002 .

TANG Y ， LI M ， WANG J X ， et al . CytoNCA：a cytoscape plugin for centrality analysis and evaluation of protein interaction networks [J ] . Biosystems ， 2015 ， 127 ： 67 - 72 .

JIN S ， BORKHUU O ， BAO W ， et al . Signaling pathways in thyroid cancer and their therapeutic implications [J ] . J Clin Med Res ， 2016 ， 8 （ 4 ）： 284 - 296 .

YUAN Y M ， WU D P ， HOU Y F ， et al . Wnt signaling：modulating tumor-associated macrophages and related immunotherapeutic insights [J ] . Biochem Pharmacol ， 2024 ， 223 ： 116154 .

MO Y Z ， WANG Y M ， ZHANG L S ， et al . The role of Wnt signaling pathway in tumor metabolic reprogramming [J ] . J Cancer ， 2019 ， 10 （ 16 ）： 3789 - 3797 .

CHEN T Y ， ZHOU M ， LIN M Q ， et al . Research progress on the SERPINE1 protein and chronic inflammatory di-seases of the upper respiratory tract：a literature review [J ] . Int Arch Allergy Immunol ， 2021 ， 182 （ 11 ）： 1097 - 1102 .

MORROW G B ， MUTCH N J . Past，present，and future perspectives of plasminogen activator inhibitor 1（PAI-1） [J ] . Semin Thromb Hemost ， 2023 ， 49 （ 3 ）： 305 - 313 .

CHEN S J ， LI Y Q ， ZHU Y H ， et al . SERPINE1 over-expression promotes malignant progression and poor prognosis of gastric cancer [J ] . J Oncol ， 2022 ， 2022 ： 2647825 .

WANG Y G ， WANG J Y ， GAO J C ， et al . The expression of SERPINE1 in colon cancer and its regulatory network and prognostic value [J ] . BMC Gastroenterol ， 2023 ， 23 （ 1 ）： 33 .

KUBALA M H ， DECLERCK Y A . The plasminogen activator inhibitor-1 paradox in cancer：a mechanistic understanding [J ] . Cancer Metastasis Rev ， 2019 ， 38 （ 3 ）： 483 - 492 .

SAKAMOTO H ， KOMA Y I ， HIGASHINO N ， et al . PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages [J ] . Lab Invest ， 2021 ， 101 （ 3 ）： 353 - 368 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of imperatorin on malignant biological behavior of gastric cancer cells by regulating ThPOK expression

Effects of brusatol on the malignant biological behavior of ovarian cancer cells by regulating SPHK1/S1P/S1PR3 signaling pathway

Related Author

CHEN Lan

XIA Lingli

CHEN Ying

ZHANG Gang

WEN Feng

ZHONG Mingyan

YANG Fan

LI Haizhen

Related Institution

Dept. of Gastroenterology， Wuhan Sixth Hospital Affiliated to Jianghan University

Dept. of Gastroenterology， Central Theater Command General Hospital

Dept. of Pharmacy， Jiujiang Maternal and Child Health Care Hospital

Dept. of Gynaecology， Jiujiang Maternal and Child Health Care Hospital

Dept. of Pharmacy， the Affiliated Hospital of Jiujiang University

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰